Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US…
News
Embecta acquires Owen Mumford for $172.6m
Valar Labs hits US first with breakthrough designation for AI bladder cancer test
PainTEQ announces US launch of SI joint implant
FDA clears Glooko’s cloud-based insulin dosing platform
Butterfly Medical raises $21m in funds for BPH device development
Biopharma industry endorses Pazdur for FDA commissioner role
BlueWind Medical raises $47.8m to advance commercialisation efforts for UUI treatment
